Skip to main content
Equibles

UBS Group AG

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,257,264
-$624,078 QoQ
Shares Held
365,574
-18.7% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. KYTX ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,257,264 365,574
2026-03-31 $3,881,342 449,750
2025-12-31 $1,900,556 202,187
2025-09-30 $944,532 157,422
2025-06-30 $301,344 98,158
2025-03-31 $342,902 177,670
2024-12-31 $760,726 203,403
2024-09-30 $40,078 8,196
2024-06-30 $72,330 9,644
2024-03-31 $618,465 24,898